VenetoclaxClinical tumour lysis syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1947卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35548-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：408 / 408

相关论文

共 50 条

[1] NilotinibFirst report of tumour lysis syndrome: case report
Reactions Weekly, 2008, 1193 (1) : 21 - 21
[2] BromopyruvateFirst report of tumour lysis syndrome: case report
Reactions Weekly, 2012, 1405 (1) : 11 - 11
[3] Case report: Acute tumour lysis syndrome
Chuah, CTH
Lim, LC
ANNALS ACADEMY OF MEDICINE SINGAPORE, 2001, 30 (01) : 55 - 57
[4] AntineoplasticsExacerbation of tumour lysis syndrome: case report
Reactions Weekly, 2021, 1876 (1) : 43 - 43
[5] ThalidomideFirst report of tumour lysis syndrome: case report
Reactions Weekly, 2002, 908 (1) : 10 - 11
[6] EribulinFirst report of tumour lysis syndrome: case report
Reactions Weekly, 2019, 1743 (1) : 86 - 86
[7] VenetoclaxLaboratory tumour lysis syndrome: case report
Reactions Weekly, 2019, 1745 (1) : 266 - 266
[8] SorafenibFatal tumour lysis syndrome: case report
Reactions Weekly, 2010, 1292 (1) : 34 - 34
[9] RituximabHyperacute tumour lysis syndrome: case report
Reactions Weekly, 2015, 1549 (1) : 217 - 217
[10] AntineoplasticsFatal tumour lysis syndrome: case report
Reactions Weekly, 2000, 809 (1) : 7 - 7

← 1 2 3 4 5 →